Depo-Eligard
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Depo-Eligard, covering 2010-01-22 to 2014-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients